TipRanks
Arbutus Biopharma Corporation (ABUS)
NASDAQ:ABUS
US Market
ABUS
Arbutus Biopharma
RESEARCH TOOLSreports
Want to see ABUS full AI Analyst Report?

Arbutus Biopharma (ABUS) Stock News & Sentiment

1,285 Followers
Arbutus Biopharma Launches US$230 Million Dutch Auction Share Buyback
Premium
Company Announcements
Arbutus Biopharma Launches US$230 Million Dutch Auction Share Buyback
23d ago
ABUS
Arbutus Biopharma Announces Major Share Repurchase Tender Offer
Premium
Company Announcements
Arbutus Biopharma Announces Major Share Repurchase Tender Offer
26d ago
8K
ABUS
Arbutus Boosts Cash With Moderna Settlement, Advances Hepatitis B Program
Premium
Company Announcements
Arbutus Boosts Cash With Moderna Settlement, Advances Hepatitis B Program
1M ago
ABUS
Arbutus Biopharma (ABUS) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Arbutus Biopharma (ABUS) Q2 Earnings Cheat Sheet
2M ago
ABUS
Arbutus Biopharma Reshapes Strategy After Moderna Settlement
Premium
Company Announcements
Arbutus Biopharma Reshapes Strategy After Moderna Settlement
2M ago
8K
ABUS
Arbutus Biopharma Shareholders Approve New 2026 Incentive Plan
Premium
Company Announcements
Arbutus Biopharma Shareholders Approve New 2026 Incentive Plan
4M ago
8K
ABUS
Arbutus Biopharma Shareholders Approve New 2026 Incentive Plan
Premium
Company Announcements
Arbutus Biopharma Shareholders Approve New 2026 Incentive Plan
4M ago
8K
ABUS
More ABUS News >

ABUS News on the Web

Could Arbutus Biopharma Corporation (ABUS) Turn its Moderna, Inc. (MRNA) Settlement Into a Lasting Biotech Advantage?
Insider Monkey
Bullish
Arbutus Biopharma Reshapes Strategy After Moderna Settlement
TipRanks News
Bullish
Arbutus Biopharma (ABUS) Files Lawsuits Against Pfizer and BioNTech Over Patent Dispute
GuruFocus News
Bullish
Arbutus Biopharma expects to return $230M in capital to shareholders
TipRanks News
Bullish
Arbutus initiates patent infringement actions against Pfizer, BioNTech
TipRanks News
Bullish
Arbutus Biopharma receives $178M settlement agreement from Moderna
TipRanks News
Bullish
Arbutus Biopharma Shareholders Approve New 2026 Incentive Plan
TipRanks News
Neutral
Arbutus Biopharma (ABUS) Reports Strong Q1 Earnings with $0.87 EPS
GuruFocus News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average2.5 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ABUS’s Media Buzz Sentiment?
Currently, no data Available
What is ABUS’s weekly average amount of articles?
In an average week, 2.5 articles about ABUS are published.
    What is ABUS’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    AXGNAxoGen
    BAYRYBayer
    HITIHigh Tide
    JAZZJazz Pharmaceuticals
    DXCMDexcom
    Showing the stocks with the most bullish news sentiment over the past week